Packaging
Latest Astrazeneca UK Limited Patents:
- Systems and methods for dispensing a statin medication over the counter
- COMBINATION OF ANTIBODY-DRUG CONJUGATE AND PARP1 SELECTIVE INHIBITOR
- Methods for lowering blood sugar with a gliflozin sodium-glucose cotransport 2 inhibitor pharmaceutical composition
- Methods for lowering blood sugar with a metformin pharmaceutical composition
- Methods for lowering blood sugar with a dipeptidyl peptidase-4 inhibitor pharmaceutical composition
Description
Claims
The ornamental design for packaging, as shown and described.
Referenced Cited
U.S. Patent Documents
Other references
D132820 | June 1942 | Wolteger |
D345101 | March 15, 1994 | Abrams |
D351104 | October 4, 1994 | Kapp |
D369295 | April 30, 1996 | Kobari et al. |
D415419 | October 19, 1999 | Abiteboul |
D425730 | May 30, 2000 | Murphy |
D494467 | August 17, 2004 | Ohno |
D606855 | December 29, 2009 | Jo et al. |
D629296 | December 21, 2010 | De Muynck |
- European Community Design Registration No. 000653233-0001, published in the Community Designs Bulletin No. 2007/018 on Feb. 13, 2007 (4 pages).
- European Community Design Registration No. 000653233-0002, published in the Community Designs Bulletin No. 2007/018 on Feb. 13, 2007 (3 pages).
Patent History
Patent number: D668949
Type: Grant
Filed: Dec 22, 2010
Date of Patent: Oct 16, 2012
Assignee: Astrazeneca UK Limited (London)
Inventors: Robert Hipperson (Macclesfield), Sebastien Corvez (Dunkirk), Mark Kraaijenbrink (Dunkirk)
Primary Examiner: Thomas Johannes
Attorney: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Application Number: 29/381,670
Type: Grant
Filed: Dec 22, 2010
Date of Patent: Oct 16, 2012
Assignee: Astrazeneca UK Limited (London)
Inventors: Robert Hipperson (Macclesfield), Sebastien Corvez (Dunkirk), Mark Kraaijenbrink (Dunkirk)
Primary Examiner: Thomas Johannes
Attorney: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Application Number: 29/381,670
Classifications
Current U.S. Class:
D9/423